Increased recognition of the prevalence of human babesiosis in the United S
tates, together with rising concern about the potential for transmission of
this infection by blood transfusion, has provided motivation to develop de
finitive serologic and molecular tests for the causative agent, Babesia mic
roti. To develop more sensitive and specific assays for B. microti, we scre
ened a genomic expression library with patient serum pools. This screening
resulted in the identification of three classes of novel genes and an addit
ional two novel, unrelated genes, which together encode a total of 17 uniqu
e B. microti antigens. The first class (BMN1-2 family) of genes encodes sev
en closely related antigens with a degenerate six-amino-acid repeat that sh
ows limited homology to Plasmodium sp, merozoite and sporozoite surface ant
igens. A second class (BMN1-8 family) of genes encodes six related antigens
, and the third class (BMN1-17 family) of genes encodes two related antigen
s, The two remaining genes code for novel and unrelated sequences. Among th
e three classes of antigens and remaining novel sequences, five were chosen
to code for the most immunodominant antigens (BMN1-2, -9, -15, and -17 and
MN-10). Western blot analysis with the resulting recombinant proteins indi
cated that these antigens were targets of humoral immune responses during B
. microti infection in humans.